Moreover, increasing obese population is also expected todrive the demand for urethral stricture treatment devices in the country. For instance, as per the data provided by the CDC (2021), in 2017-2018, theobesity prevalence in the country was 42.4%.
Obesity has beenassociated with increased mean urethral stricture length in obese patientscompared to patients with a normal body-mass index.
Thus, the interplay of all the aforementioned factors arelikely to fuel the market growth of urethral stricture treatment devices market in the United States during the forecast period.
Some of the key market players operating in the urethralstricture treatment devices market includes Boston ScientificCorporation, Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG,Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH,UROMED Kurt Drews KG, Med pro Medical B.V., BD, Cardinal Health.Coloplast, ConvaTec Inc, BACTIGUARD AB and others.
Also read-
